Linjing Yuan

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Selective uterine artery embolization is a valid adjuvant treatment of choriocarcinoma: a case report and literature review.

Selective uterine artery embolization is a valid adjuvant treatment of choriocarcinoma: a case report and literature review.

Journal: Frontiers in oncology

Published: August 12, 2024

SYT7 as a Potential Prognostic Marker Promotes the Metastasis of Epithelial Ovarian Cancer Cells by Activating the STAT3 Pathway.

SYT7 as a Potential Prognostic Marker Promotes the Metastasis of Epithelial Ovarian Cancer Cells by Activating the STAT3 Pathway.

Journal: Molecular carcinogenesis

Published: April 03, 2024

The MYBL2-CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages.

The MYBL2-CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages.

Journal: Cancer cell international

Published: April 19, 2023

Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy.

Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy.

Journal: Oncoimmunology

Published: May 11, 2018

Evaluation of serum CCL18 as a potential biomarker for ovarian cancer.

Evaluation of serum CCL18 as a potential biomarker for ovarian cancer.

Journal: Cancer biomarkers : section A of Disease markers

Published: October 18, 2017

miR‑149‑5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway.

miR‑149‑5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway.

Journal: International journal of oncology

Published: July 31, 2017

Serum levels of apolipoprotein E correlates with disease progression and poor prognosis in breast cancer.

Serum levels of apolipoprotein E correlates with disease progression and poor prognosis in breast cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: June 17, 2016

High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer.

High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer.

Journal: Oncotarget

Published: April 26, 2016

Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China.

Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: March 23, 2016

WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition.

WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition.

Journal: PloS one

Published: February 29, 2016

Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer.

Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer.

Journal: Molecular cancer

Published: August 12, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026